CAS 1655501-53-3

Fremanezumab

CAS: 1655501-53-3

Anti-Human CGRP Monoclonal Antibody

Ref: 3D-CLA1442

Fremanezumab

CAS: 1655501-53-3

Fremanezumab (TEV-48125) is a humanised monoclonal antibody targeting CGRP, capable of neutralising human, mouse and rat CGRP, migraine.

Purezza: 95% - 97.6% (SDS-PAGE); 95.9% (SEC-HPLC)

Colore e forma: Liquid

Peso molecolare: 145.49 kDa

Ref: TM-T76680